How do colchicine and anti-interleukin-1 agents compare in efficacy and safety for reducing the risk of recurrent pericarditis?
Patients with recurrent pericarditis
Colchicine and anti-interleukin-1 agents
Pairwise and network comparisons between colchicine and anti-interleukin-1 agents
Risk of recurrent pericarditishard clinical
Both colchicine and anti-interleukin-1 agents effectively reduce recurrent pericarditis, but anti-interleukin-1 agents have a higher rate of nonserious adverse events.
Both colchicine and anti-interleukin-1 agents are effective in reducing the risk of recurrent pericarditis. Anti-interleukin-1 agents are associated with more frequent nonserious adverse events, but evidence on serious adverse events remains inconclusive.
Building similarity graph...
Analyzing shared references across papers
Loading...
Muhammad Ehsan
Alveena Batool Syed
Biah Mustafa
SHILAP Revista de lepidopterología
Journal of the American Heart Association
Northwestern University
Cleveland Clinic
University of Udine
Building similarity graph...
Analyzing shared references across papers
Loading...
Ehsan et al. (Tue,) studied this question.
www.synapsesocial.com/papers/69da403e387cf706986867a8 — DOI: https://doi.org/10.1161/jaha.125.041007